查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945410

2026年全球鼻内给药装置市场报告

Intranasal Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，鼻腔给药装置的市场规模呈现显着成长，预计将从2025年的650.9亿美元成长到2026年的707.7亿美元，复合年增长率达8.7%。过去几年的增长可归因于呼吸系统和鼻腔疾病盛行率的上升、全身给药途径中鼻腔给药的日益普及、自我给药装置的增长、鼻腔疗法核准的增加以及门诊治疗模式的扩展。

预计未来几年鼻腔给药装置市场将强劲成长，到2030年市场规模将达到991.1亿美元，复合年增长率（CAGR）为8.8%。预测期内的成长要素包括鼻腔生物製药和疫苗的研发不断推进、居家医疗对给药的需求日益增长、鼻内给药在神经系统疾病治疗中的应用不断扩大、对先进药物-​​医疗设备组合的投资不断增加，以及对提高患者依从性解决方案的日益重视。预测期内的主要趋势包括精准鼻内给药系统的日益普及、对非侵入性给药需求的增长、多剂量鼻内给药装置的不断发展、更便于患者使用的药物剂型不断增加，以及对快速药物吸收的日益关注。

预计未来几年，慢性病盛行率的上升将推动鼻腔给药装置市场的成长。慢性病是指持续一年以上且需要持续医疗照护或限制日常活动，或两者兼具的疾病。鼻腔给药装置透过提供一种非侵入性且有效的给药方式，用于慢性病的治疗。这些装置可将药物直接输送到标靶，具有方便、易用和吸收迅速的优点。例如，根据英国政府机构国家医疗服务体系（NHS）的数据，截至2024年6月，英格兰有第二型糖尿病风险的人数将从2022年的3,066,330人增加到3,615,330人，另有549,000人将被诊断为非糖尿病性高血糖（糖尿病前期）。因此，慢性病盛行率的上升趋势正在推动鼻腔给药装置市场的扩张。

鼻内给药技术市场的领先製药公司正积极研发新型改良产品，以提供创新的给药方式并维持市场地位。例如，2023年1月，总部位于美国的药物输送和製药公司AptarGroup推出了APF Futurity，这是首款可回收、无金属、多剂量鼻喷剂，用于鼻内输送生理食盐水和类似的非处方药（OTC）製剂。该产品采用聚烯材料製成，不含金属零件或回收抑制剂，减少了回收过程中的分类工作，并有助于生产更高品质的再生材料。值得一提的是，APF Futurity是一款高度可回收的鼻喷泵，并已获得欧洲Cyclos HTP认证的AA级回收标准。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球鼻内给药装置市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网 (IoT)、智慧基础设施和互联生态系统
    • 人工智慧和自主智能
  • 主要趋势
    • 扩大精准鼻腔给药系统的应用
    • 对非侵入性药物输送方法的需求日益增长
    • 扩大多剂量鼻腔给药装置的研发
    • 拓展更方便病人使用的给药方式
    • 人们越来越关注药物的快速吸收

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 居家医疗保健服务提供者
  • 製药公司
  • 门诊治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球鼻内给药装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球鼻内给药装置市场规模、比较及成长率分析
  • 全球鼻内给药装置市场表现：规模与成长，2020-2025年
  • 全球鼻内给药装置市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 副产品
  • 粉末输送装置、液体输送装置、压力定量吸入器及其他产品
  • 按剂量
  • 单剂量，多剂量
  • 透过使用
  • 慢性阻塞性肺病（COPD）、鼻炎、囊肿纤维化、鼻塞、气喘及其他适应症
  • 最终用户
  • 医院、诊所、居家医疗和其他最终用户
  • 按类型细分：粉末输送装置
  • 单剂量粉剂给药装置，多剂量粉剂给药装置
  • 按类型细分：液体计量装置
  • 单剂量液体装置、多剂量液体装置
  • 按类型细分：压力定量吸入器
  • 吸气式定量吸入器，常规定量吸入器
  • 按类型细分：其他产品
  • 凝胶输送装置、雾化器和鼻喷剂

第十章 区域与国家分析

  • 全球鼻内给药装置市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球鼻内给药装置市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 鼻内给药装置市场：竞争格局及市场占有率（2024年）
  • 鼻内给药装置市场：公司估值矩阵
  • 鼻内给药装置市场：公司概况
    • Johnson and Johnson Inc.
    • Novartis AG
    • AstraZeneca plc.
    • GlaxoSmithKline Plc
    • 3M Company

第37章：其他领先和创新企业

  • Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development SA, Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年鼻内给药装置市场：提供新机会的国家
  • 2030年鼻内给药装置市场：充满新机会的细分市场
  • 2030年鼻内给药装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIDDD02_G26Q1

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

Tariffs are impacting the intranasal drug delivery devices market by increasing costs of imported polymers, precision plastic components, metered-dose mechanisms, and pharmaceutical-grade materials used in sprays, inhalers, and nasal devices. Manufacturers in North America and Europe are particularly affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising production costs and extending development timelines. However, they are also encouraging localized device manufacturing, regional supplier diversification, and investments in cost-optimized nasal delivery technologies.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $65.09 billion in 2025 to $70.77 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing prevalence of respiratory and nasal disorders, rising use of nasal route for systemic drug delivery, growth in self-administration drug devices, increasing approvals of intranasal therapies, expansion of outpatient treatment models.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $99.11 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing development of biologics and vaccines via nasal delivery, rising demand for homecare drug administration, expansion of intranasal delivery for neurological therapies, growing investments in advanced drug-device combinations, increasing focus on patient compliance solutions. Major trends in the forecast period include increasing adoption of precision nasal delivery systems, rising demand for non-invasive drug administration, growing development of multi-dose nasal devices, expansion of patient-friendly drug delivery formats, enhanced focus on rapid drug absorption.

The rising prevalence of chronic diseases is anticipated to drive the growth of the intranasal drug delivery devices market in the coming years. Chronic diseases are conditions that persist for one year or longer and require continuous medical care, limit daily activities, or both. Intranasal drug delivery devices are used in the management of chronic diseases by offering a non-invasive and effective method of medication administration. These devices enable drugs to be delivered directly to the targeted area, providing convenience, ease of use, and rapid absorption. For example, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the number of individuals in England at risk of developing type 2 diabetes increased to 3,615,330 from 3,066,330 in 2022, with more than half a million additional people (549,000) identified as having non-diabetic hyperglycemia, or pre-diabetes. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the intranasal drug delivery devices market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In January 2024, Kindeva Drug Delivery, a US-based provider of drug-device combination product development and manufacturing, acquired Summit Biosciences Inc. for an undisclosed amount. Through this acquisition, Kindeva seeks to enhance its drug-delivery platform by incorporating specialized intranasal formulation and manufacturing capabilities, allowing it to support biopharma clients across a wider range of complex combination products. Summit Biosciences Inc. is a US-based contract development and manufacturing organization specializing in intranasal drug-delivery solutions.

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
  • 2) By Dosage: Unit-Dose; Multi-Dose
  • 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
  • 4) By End User: Hospitals; Clinics; Homecare; Other End Users
  • Subsegments:
  • 1) By Powder Delivery Device: Single-Dose Powder Device; Multi-Dose Powder Device
  • 2) By Liquid Delivery Device: Single-Dose Liquid Device; Multi-Dose Liquid Device
  • 3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs; Conventional pMDIs
  • 4) By Other Products: Gel Delivery Device; Nebulizers; Nasal Sprays
  • Companies Mentioned: Johnson and Johnson Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Becton Dickinson and Company; Teva Pharmaceutical Industries Ltd.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Recipharm AB; Nemera Development S.A.; Consort Medical plc.; Vectura Group plc.; OptiNoset Inc.; Flamel Technologies; Aegis Therapeutics LLC; PendoPharm Inc.; Kurve Technology Inc.; Impel NeuroPharma; Impexium Medical Products; ENT Technologies Pty. Ltd.; Neurelis Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Intranasal Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Intranasal Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Intranasal Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Intranasal Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Industry 4.0 And Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
    • 4.1.5 Artificial Intelligence And Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Precision Nasal Delivery Systems
    • 4.2.2 Rising Demand For Non-Invasive Drug Administration
    • 4.2.3 Growing Development Of Multi-Dose Nasal Devices
    • 4.2.4 Expansion Of Patient-Friendly Drug Delivery Formats
    • 4.2.5 Enhanced Focus On Rapid Drug Absorption

5. Intranasal Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Homecare Providers
  • 5.4 Pharmaceutical Companies
  • 5.5 Ambulatory Care Centers

6. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intranasal Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Intranasal Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intranasal Drug Delivery Devices Market Segmentation

  • 9.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
  • 9.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Unit-Dose, Multi-Dose
  • 9.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
  • 9.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Homecare, Other End Users
  • 9.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Powder Device, Multi-Dose Powder Device
  • 9.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Liquid Device, Multi-Dose Liquid Device
  • 9.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breath-Actuated PMDIs, Conventional pMDIs
  • 9.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gel Delivery Device, Nebulizers, Nasal Sprays

10. Intranasal Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intranasal Drug Delivery Devices Market

  • 11.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intranasal Drug Delivery Devices Market

  • 12.1. China Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intranasal Drug Delivery Devices Market

  • 13.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intranasal Drug Delivery Devices Market

  • 14.1. Japan Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intranasal Drug Delivery Devices Market

  • 15.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intranasal Drug Delivery Devices Market

  • 16.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intranasal Drug Delivery Devices Market

  • 17.1. South Korea Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intranasal Drug Delivery Devices Market

  • 18.1. Taiwan Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intranasal Drug Delivery Devices Market

  • 19.1. South East Asia Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intranasal Drug Delivery Devices Market

  • 20.1. Western Europe Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intranasal Drug Delivery Devices Market

  • 21.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intranasal Drug Delivery Devices Market

  • 22.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intranasal Drug Delivery Devices Market

  • 23.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intranasal Drug Delivery Devices Market

  • 24.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intranasal Drug Delivery Devices Market

  • 25.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intranasal Drug Delivery Devices Market

  • 26.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intranasal Drug Delivery Devices Market

  • 27.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intranasal Drug Delivery Devices Market

  • 28.1. North America Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intranasal Drug Delivery Devices Market

  • 29.1. USA Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intranasal Drug Delivery Devices Market

  • 30.1. Canada Intranasal Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intranasal Drug Delivery Devices Market

  • 31.1. South America Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intranasal Drug Delivery Devices Market

  • 32.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intranasal Drug Delivery Devices Market

  • 33.1. Middle East Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intranasal Drug Delivery Devices Market

  • 34.1. Africa Intranasal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Segmentation By Dosage, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intranasal Drug Delivery Devices Market Regulatory and Investment Landscape

36. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Intranasal Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Intranasal Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Intranasal Drug Delivery Devices Market Company Profiles
    • 36.3.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

37. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

  • Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products

38. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

40. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Intranasal Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Intranasal Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Intranasal Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer